NCT00807339View on ClinicalTrials.gov

CyberKnife for Unresectable Renal Tumors

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

January 1, 2014

Study Completion Date

August 20, 2014

Conditions
Renal Cancer
Interventions
RADIATION

Stereotactic radiation

Dose escalation three consecutive treatments

DEVICE

CyberKnife Robotic Radiosurgery System

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER

NCT00807339 - CyberKnife for Unresectable Renal Tumors | Biotech Hunter | Biotech Hunter